BIOCARDIA, INC. : Other Events, Financial Statements and Exhibits (form 8-K)

Published: 2021-10-21 09:28:05 ET BCDA

Item 8.01 Other Events.

On October 21, 2021, BioCardia, Inc. (the "Company") issued a press release announcing the treatment of the first patient in its Phase III pivotal CardiAMP Cell Therapy Chronic Myocardial Ischemia Trial for patients with no option chronic myocardial ischemia with refractory angina. The first patient was treated with the investigational CardiAMP autologous cell therapy at the University of Wisconsin in Madison, by Interventional Cardiologist and Associate Professor of Medicine, Amish Raval, M.D., and supported by Peiman Hamatti, M.D., Bone Marrow Transplantation Hematologist and Professor of Medicine. A copy of the press release is attached hereto as Exhibit 99.1 to this current report on Form 8-K and is incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.

--------------------------------------------------------------------------------